AI Article Synopsis
- Advanced hallux rigidus treatment in older, sedentary patients with poor bone quality poses challenges for orthopedic surgeons, making traditional methods like osteotomy and fusion problematic.
- The Keller resection arthroplasty has had mixed results, indicating a need for better alternatives.
- Crescentic oblique basilar resection arthroplasty emerges as a promising option, suitable for both older patients and more active individuals who want to preserve some motion in the first MTP joint while avoiding fusion.
Article Abstract
The treatment of advanced hallux rigidus in an older, more sedentary population with poor bone stock or comorbidities that may make corrective osteotomy, fusion, and implant fixation more problematic has frequently been an issue for orthopedic surgeons. The traditional Keller resection arthroplasty has not fared well because of various problems. Crescentic oblique basilar resection arthroplasty is a viable surgical treatment alternative for older, more sedentary patients who have advanced hallux rigidus with or without hallux valgus. This may also be a good alternative procedure in a more active patient who wishes to avoid fusion of the joint while maintaining some first MTP motion.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fcl.2008.11.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Range of Flexion Improvement in Degenerative Stages of the First Metatarsophalangeal Joint () with Cross-Linked Hyaluronic Acid: A Cadaveric Study.
J Funct Morphol Kinesiol
December 2024
Human Anatomy and Embryology Unit, Experimental Pathology and Therapeutics Department, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 Hospitalet, Spain.
Background: Viscosupplementation consists of intraarticular hyaluronic acid injections applied to treat pain and improve joint mobility. The objective of the study was to analyze the improvement of the range of mobility of the first metatarsophalangeal joint with a single dose of cross-linked hyaluronic acid.
Methods: Ten fresh frozen specimens of feet sectioned below the knee were selected.
Modern Treatment of Hallux Rigidus by Cheilectomy: A Systematic Review of Patient-Reported Outcomes in Minimally Invasive Techniques.
Foot Ankle Orthop
October 2024
Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT, USA.
Background: Minimally invasive cheilectomy is becoming a more prominent surgical approach in the management of mild to moderate hallux rigidus. This systematic review aims to analyze and present the current literature on patient-reported outcomes following minimally invasive (MIS) cheilectomy for mild to moderate hallux rigidus.
Methods: PubMed, Cochrane Central Register of Controlled Trials, and Scopus databases were searched in April 2024.
Reviewing Evidence and Patient Outcomes of Cheilectomy for Hallux Rigidus: A Systematic Review and Meta-Analysis.
J Clin Med
November 2024
1st Orthopaedics and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Cheilectomy is a joint-sparing surgery for the treatment of moderate stages of Hallux Rigidus (HR). The purpose of this systematic review was to assess the clinical outcomes, range of motion (ROM), complications, and revision rates associated with cheilectomy. A literature search of the PubMed, Scopus, and Cochrane databases was performed.
View Article and Find Full Text PDFDoes Decompressive Chevron Osteotomy Decrease Subchondral Bone Density of the First Metatarsophalangeal Joint in Hallux Rigidus?
Foot Ankle Int
December 2024
Service de Chirurgie Orthopédique, Clinique Trenel, Sainte-Colombe, France.
Background: To investigate the impact of decompressive chevron osteotomy on subchondral bone density at the first metatarsophalangeal (MTP) joint.
Methods: Sixteen feet (12 patients) with hallux rigidus underwent decompressive chevron osteotomy. Standing cone beam 3D computed tomography (3DCT) were assessed preoperatively and at 4-month follow-up, and clinical data were collected.
Two-Year Clinical Outcomes of Patients Undergoing Synthetic Cartilage Arthroplasty for First Metatarsophalangeal Osteoarthritis.
Cureus
December 2024
Trauma and Orthopaedics, North Middlesex University Hospital NHS Trust, London, GBR.
Background Severe osteoarthritis (OA) of the first metatarsophalangeal joint (MTPJ) is usually treated by arthrodesis, which results in a loss of mobility in the joint. Cartiva (Stryker Corporation, Kalamazoo, USA) is a synthetic cartilage implant (SCI) designed to repair osteochondral defects in the treatment of the first MTP OA. Treatment using the Cartiva SCI should relieve symptoms of OA whilst sparing motion in the first MTPJ and may provide a superior alternative to arthrodesis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!